From the Guidelines
Topical corticosteroids, such as fluticasone and mometasone, are commonly used examples.
Examples of Topical Corticosteroids
- Fluticasone
- Mometasone
- Clobetasol
- Halobetasol propionate
- Triamcinolone acetonide
- Dexamethasone
These topical corticosteroids can be grouped into seven potency classes 1, with high potency corticosteroids, such as clobetasol, being used with caution in highly sensitive skin areas to avoid skin atrophy. Low to medium potency corticosteroids, such as fluticasone and mometasone, can be used for longer periods to treat chronic atopic dermatitis involving the trunk and extremities 1. In addition, topical corticosteroids like dexamethasone can be used to reduce symptoms and scarring in severe cases of adenoviral keratoconjunctivitis 1.
In general, the basic principle is to use the least potent preparation required to keep the eczema under control 1, and when possible, the corticosteroids should be stopped for short periods. It is also important to note that topical corticosteroids should be used with caution in infants and young children due to the increased risk of adrenal suppression from potent corticosteroids 1.
From the Research
Types of Topical Corticosteroids
There are various types of topical corticosteroids available, including:
- Ointments
- Creams
- Lotions
- Gels
- Foams
- Oils
- Solutions
- Shampoos 2
Classification of Topical Corticosteroids
Topical corticosteroids are classified by strength and the risk of adverse effects, such as atrophy, striae, rosacea, telangiectasias, purpura, and other cutaneous and systemic reactions 2
Examples of Conditions Treated with Topical Corticosteroids
Topical corticosteroids are used to treat a variety of dermatologic conditions, including:
- Psoriasis
- Atopic dermatitis
- Vitiligo
- Eczema
- Phimosis
- Acute radiation dermatitis
- Lichen sclerosus 3
Factors to Consider When Selecting a Topical Corticosteroid
The selection of a topical corticosteroid depends on several factors, including:
- The dermatosis being treated and its anticipated corticosteroid responsiveness
- The anatomic site of the dermatosis
- The potency of the corticosteroid
- The appropriateness of the delivery vehicle
- The existence of particular patient factors that can affect response to therapy 4